MVMaria K. Vasilchenko

Maria K. Vasilchenko

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Maria K. Vasilchenko has a total of 39 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Association of metabolic-associated fatty liver disease with arterial stiffness: the role of vitamin D

    by Valery I. Podzolkov, Anna E. Bragina, Yulia N. Rodionova, Maria K. Vasilchenko, Andrey V. Podzolkov, Maria V. Vetluzhskaya, Daria V. Akvitskaya, Klimentiy N. Eltsov, Kirill V. Dementev, Nikita M. Pshenichnikov

    Aim. To investigate the relationship between vitamin D levels, metabolic-associated fatty liver disease (MAFLD), and arterial stiffness. Materials and methods. This study included 303 patients with a median age of 55 [40; 65] years. All participants underwent duplex ultrasonography with assessment of carotid extra-media thickness (EMT), and liver transient elastography with evaluation of the attenuation coefficient (AC) transthoracic echocardiography for measurement of epicardial adipose tissue thickness (EAT). MAFLD was diagnosed based on hepatic steatosis combined with overweight/obesity and at least two metabolic risk factors. Arterial stiffness was evaluated using the cardio-ankle vascular index (CAVI), measured by sphygmomanometry with the VaSera-1000 system FUCUDA DENSHI (Japan). Serum 25-hydroxyvitamin D levels were measured in all participants. Statistical analysis was performed using Statistica 12.0 software. Results. Patients were divided into 4 groups depending on their vitamin D levels. High arterial stiffness was significantly more frequent in patients with severe vitamin D deficiency compared with those with insufficiency and optimal levels (40% vs 19.5%; p=0.006; 40% vs 0%; p0.0001 respectively). The cardio-ankle vascular index (CAVI) was significantly higher in the severe deficiency group compared with the optimal vitamin D group (7.5 [6.5; 8.8] vs 6.6 [5.8; 7.5]; p=0.03). Significant correlations were observed between CAVI and EMT, EAT, AC, and the presence of MAFLD. Vitamin D levels were negatively correlated with AC and MAFLD. ROC analysis demonstrated the highest diagnostic accuracy for detecting increased arterial stiffness using a combined model (AUC vit D + AC + EMT =0.823; p0.0001). Conclusion. Vitamin D is associated with arterial stiffness and ectopic fat deposition, while its combination with AC and EMT provides high diagnostic accuracy for identifying patients at increased cardiometabolic risk.

  • Relationships between perivascular adipose tissue and vascular wall remodeling: A systematic review and meta-analysis

    by Anna Bragina, Yulia Rodionova, Konstantin Osadchiy, Maria Vasilchenko, Natalia Druzhinina, Aleksandr Suvorov, Alexander Fomin, Miroslava Pilipenko, Valeriy Podzolkov

    Background: The association between ectopic fat and vascular stiffness is poorly studied and has never been systematically reviewed. We conducted a systematic review and meta-analysis aimed to systematize current literature and investigate the association of perivascular adipose tissue (PVAT) and the indices of vascular wall remodeling and arterial stiffness, such as pulse wave velocity (PWV), augmentation index (AI), cardio–ankle vascular index (CAVI), endothelium-dependent vasodilation (EDV), and intima–media thickness (IMT). Methods: A systematic literature review was performed according to PRISMA guidelines via searching PubMed, Scopus, and Web of Science databases using specific keywords. Data were extracted from eight studies with 1244 participants that fit the criteria and analyzed using a random-effects model. Results: Our pooled analysis revealed stronger correlations between carotid–femoral pulse wave velocity (cfPWV), AI, and the density of thoracic periaortic adipose tissue ( r = 0.56, p < 0.05, n = 14); carotid extra-media thickness (EMT) and average daily PWV in the aorta ( r = 0.56, p < 0.05, n = 84); and thoracic periaortic fat volume and CAVI ( r = 0.49, p < 0.05, n = 318). Conclusion: Our results demonstrate the association between PVAT and vascular wall remodeling, emphasizing the need for early detection of dysfunctional PVAT as the contributor to higher cardiovascular risk, not only in patients with risk factors and cardiovascular diseases, but also in healthy individuals. (PROSPERO Registration No.: CRD42023443139)


  • Open Access

    Phenotypic clusters of obesity: gender, clinical, laboratory and genetic characteristics

    by Valery I. Podzolkov, Anna E. Bragina, Maria K. Vasilchenko, Konstantin K. Osadchiy, Miroslava O. Pilipenko, Viktoriia A. Antonenko, Lamiya B. Mansimova, Yulia N. Rodionova

    Aim. To identify phenotypic clusters of patients with various types of obesity and to study their gender, clinical, laboratory and genetic characteristics. Materials and methods. 100 patients (47 men and 53 women, median age 58.5 [50; 69] years) were included in the cross-sectional study. All patients underwent chest and retroperitoneal space computed tomography with the calculation of pericardial, perivascular adipose tissue volumes and the thickness of perirenal fat. Alleles and genotypes of the peroxisome proliferator activated receptor gamma (PPARG) rs1801282 polymorphism, angiotensin II receptor type 1 (AGTR1) rs5186 polymorphism, and vascular endothelial growth factor A (VEGF-A) rs699947 polymorphism were identified in all patients. Cluster analysis was performed with python version 3.11. using the k-means algorithm. Silhouette value 0.2. Results. Cluster 1 (n=36) consisted of middle-aged patients (men – 38.9%) with hypertension (HTN) – 100%, combined obesity [general obesity (GO) – 61%, abdominal obesity (AO) – 100%, ectopic obesity – 80.5%] and dyslipidaemia (77.8%). Cluster 2 included 14 patients: elderly (77.8%) men (71.4%) with HTN (100%), combined obesity (GO – 92.8%, AO – 85.7%, ectopic obesity – 100%), high incidence of dyslipidaemia (92.8%) and target organ damage. Cluster 3 consisted of 21 patients, mostly elderly (87.5%) women (76.2%) with HTN (90.1%), AO (80.9%), without GO (0%) and perirenal obesity (0%). Cluster 4 consisted of 29 patients, mostly young men without HTN (0%) with isolated AO (72.4%). The highest prevalence of risky alleles of the studied polymorphisms was found in cluster 2 (25, 32.1, 64.3%). The frequency of risky alleles was low 10.3, 20.7 and 43.1% in the most metabolically favourable cluster 4 compared to cluster 2. Conclusion. We identified 4 clusters of obese patients in our study. Among them, the most unfavorable from a metabolic and genetic point of view was cluster 2, and the most favourable was cluster 4.


  • Open Access

    Polymorphism of the PPARG, AGTR1, VEGF-A genes: frequency and association with obesity phenotypes

    by A. E. Bragina, M. K. Vasilchenko, Yu. N. Rodionova, K. K. Osadchiy, A. P. Muravlev, M. A. Voronkov, E. A. Aleksandrova, V. I. Podzolkov

    Aim. To assess the association of the allele and genotype frequencies of following single nucleotide polymorphisms: rs1801282 of the peroxisome proliferator-activated receptor gamma (PPARG) gene, rs5186 of the angiotensin II receptor type 1 (AGTR1) gene, rs699947 of the vascular endothelial growth factor A (VEGF-A) gene in patients with various phenotypes of abdominal (AO) and ectopic (EO) obesity.Material and methods. The cross-sectional study included 100 Caucasian patients (47 men, 53 women, median age 58,5 [50;69] years). All patients underwent chest and retroperitoneal computed tomography with calculation of the volumes of perivascular (PVAT) and pericardial (PAT) adipose tissue, and perirenal fat thickness (PFT). PAT volume ≥3,2 cm3, PVAT volume ≥0,4 cm3, PFT thickness ≥1,91 cm were considered criteria for pericardial (PCO), perivascular (PVO) and perirenal (PRO) obesity. Alleles and genotypes of polymorphic markers of candidate genes were identified in all patients.Results. In the distribution of genotypes of the polymorphic marker AGTR1 rs5186, statistical significance (p=0,014) was found between the group with any type of obesity and patients without obesity; the distribution of genotypes differed from the Hardy-Weinberg equilibrium (HWE) in the EO (p=0,0009) and mixed obesity (p=0,05) groups. With regard to the marker VEGF-A rs699947, a significant increase in the frequency of the mutant allele C (62,5%, 50%, 46,3%, 47,75%, respectively) was found in the EO, AO, and EO+AO groups with any type of obesity compared to the non-obese group (40%) (χ2=10,806; p=0,013). A deviation of the frequency of VEGF-A rs699947 genotypes from HWE was found in the EO group (p=0).Conclusion. Our data suggest that single nucleotide polymorphisms PPARG rs1801282, AGTR1 rs5186, VEGF-A rs699947 may be associated with fat distribution in the body and be markers of various EO and AO phenotypes. Verification of our hypothesis requires additional studies with the inclusion of larger samples and comparison groups.

  • Open Access

    Relationships of Thickness of Perirenal Fat with Urinary Levels of MCP-1 and NGAL in Patients with Hypertension

    by Anna Bragina, Yulia Rodionova, Konstantin Osadchiy, Daria Bayutina, Maria K. Vasilchenko, Alexander Fomin, Valeriy Podzolkov

    Anna Bragina, Yulia Rodionova, Konstantin Osadchiy, Daria Bayutina, Maria K. Vasilchenko, Alexander Fomin, Valeriy Podzolkov. J Obes Metab Syndr -0001;0:0-. https://doi.org/10.7570/jomes24002


  • Open Access

    Ectopic adipose tissue: association of obesity phenotypes with integral metabolic indices of obesity

    by V. I. Podzolkov, A. E. Bragina, Yu. N. Rodionova, K. K. Osadchiy, M. K. Vasilchenko, Zh. M. Sizova, E. V. Mospanova, N. S. Litvinenko, I. D. Muradova, D. V. Akvitskaya

    Aim. To study the relationship and predictive value of integral metabolic indices of obesity in the identification of ectopic obesity.Material and methods. The study included 326 patients (146 men and 180 women, mean age 61±9 years). Anthropometric data, degree of obesity, body mass index (BMI), waist circumference (WC), sagittal abdominal diameter (SAD), body obesity index (BAI), visceral obesity index (VAI), lipid accumulation index (LAP), triglycerides-glucose index (TyG) was assessed. Perivascular adipose tissue (PVAT) volume, pericardial adipose tissue (PAT) volume and thickness of perirenal fat tissue (PRF) were assessed with CT.Results. Patients were divided into groups: with isolated ectopic obesity (iEO) (n=17); with isolated abdominal obesity (iAO) (n=74); with EO variants: pericardial (PCO) (n=31), perivascular (PVO) (n=22) or perirenal (PRO) (n=33) with AO; with mixed ectopic obesity and AO (mEO+AO) (n=117), and patients without obesity (n=32). Significantly higher BMI, WC, SAD, and BAI indices were found in individuals with PCO+AO, PRO+AO and mEO+AO. The highest values of LAP were found in groups: PCO+AO, PVO+AO, PRO+AO. There was a correlation between ectopic fat depots and WC (r=0,62 for PAT, r=0,55 for PVAT and r=0,39 for PRF, p=0,01) and SAD (0,429, 0,329 and 0,435, respectively, p=0,01). Correlation was established between PAT, PRF and LAP (0,425 and 0,319, respectively, p=0,01). The highest AUC values>0,8 had models of WC and SAD in identification of PCO (0,801 and 0,801, respectively) and PRO (0,826 and 0,826, respectively). For PCO, the cut-off point of WC was 100,5 cm (specificity 72,9%, sensitivity 70,2%, p=0,000), SAD — 25 cm (specificity 73%, sensitivity 70,2%, p=0,000). For PRO, the cut-off of WC was 101 cm (specificity 71,4%, sensitivity 72,7%, p=0,000), SAD — 25 cm (specificity 71,4%, sensitivity 72,7%, p=0,000).Conclusion. Еctopic fat depots are related to the risk of metabolic disorders. Potential informative value of simple and accessible integral metabolic indices was established. WC>100,5 cm, SAD>25 cm may indicate to the presence of PCO; WC>101 cm, SAD>25 cm — to the presence of PRO.


  • Open Access

    Ectopic adipose tissue: frequency and clinical characteristics of obesity phenotypes in patients

    by V. I. Podzolkov, A. E. Bragina, Yu. N. Rodionova, K. K. Osadchiy, M. K. Vasilchenko, A. P. Muravlev, В. С. Ананьева, A. V. Balutskaya, M. O. Pilipenko

    Aim. To study the frequency and clinical characteristics of ectopic obesity in patients with different body weights and hypertension (HTN).Material and methods. The study included 326 patients (145 men and 181 women, mean age 63±8 years). Patients underwent chest and retroperitoneal space computed tomography with calculation of the volumes of perivascular adipose tissue (AT) (PVAT), pericardial AT (PAT) and perirenal fat thickness (PFT) using specialized software QCT Pro Tissue Composition Module (Mindways Software, USA). PAT volume ≥3,2 cm3, PVAT volume ≥0,4 cm3, PFT ≥1,91 cm were considered criteria for pericardial (PCO), perivascular (PVO) and perirenal (PRO) obesity.Results. When studying the prevalence of ectopic (EO) and abdominal (AO) obesity phenotypes, patients were divided into groups: 1) with isolated EO without AO (n=17), 2) with PCO and AO (n=31), 3) with PVO and AO (n=22), 4) with PRO and AO (n=33), 5) with mixed EO (PKO+PVO, or PKO+PRO, or PVO+PRO, or PKO+PVO+PRO) and AO, 6) with isolated AO without EO (n=74), 7) without obesity (n=32). Isolated EO was significantly more common in individuals with normal and overweight compared to patients with obesity: 8,9 and 12 vs 1,1% (p=0,001), respectively. The prevalence of the mixed EO+AO phenotype in obese patients was significantly higher than in patients with normal and overweight as follows: 41,7 vs 19,6 and 21,7% (p=0,001), respectively. In patients with HTN, PVO+AO was significantly more common compared to patients without HTN as follows: 12,8 vs 3% (p=0,001), respectively.Conclusion. The study results indicate the heterogeneity of the distribution of obesity phenotypes in people with different body mass index, which emphasizes the importance of taking into account all its variants, including EO, for timely and adequate cardiovascular risk assessment.


  • Open Access

    Predictors of Death in Comorbid Patients with Thrombotic Complications: a Single-Center Retrospective Cross- Sectional Study

    by A. A. Ivannikov, E. V. Kazantseva, A. M. Demianov, A. A. Kanibolotskiy, Kh. G. Alidzhanova, M. K. Vasilchenko, S. S. Petrikov

       INTRODUCTION. Despite the improvements and success in the management of thrombosis, the prognosis of thrombotic complications in comorbid patients remains extremely unfavorable. Understanding this problem suggests that it is rational to pay more attention to the prevention of thrombosis in order to avoid thrombotic complications in the first place, and there is an urgent need to improve the ability to predict the development of complications and, most importantly, death. Therefore, some inexpensive, but effective methods of risk assessment need to be developed and integrated in clinical practice.   AIM OF STUDY. To assess which laboratory markers can be associated with higher probability of fatal outcome in patients with thrombotic complications.   MATERIAL AND METHODS. The retrospective cross-sectional study included 283 patients who were admitted to the N.V. Sklifosovsky Research Institute for Emergency Medicine in 2021. Minimum age was 21 years, maximum age was 96 years, median age – 68 (59,0; 76,5) years. 161 (56,9 %) patients were males, 122 (43,1 %) – females. Group I included 226 patients with thrombotic complications; Group II included 57 (20,1 %) patients who died during hospitalization. The patients were diagnosed with the following thrombotic complications: pulmonary embolism (PE) was diagnosed in 28 (9.9 %), acute coronary syndrome with ST segment elevation in 38 (13.4 %), arterial thrombosis in 84 (29.7 %), venous thrombosis in 54 (19.1 %), thrombophlebitis in 22 (7.8 %), and systemic thromboembolism in 7 (2.5 %) patients.   RESULTS. It was established that the decrease in the estimated glomerular filtration to the levels of stage 3 (and lower) chronic kidney disease (AUC — 0,881, sensitivity — 86.92 %, specificity — 85.71 %), hemoglobin level — to less than 120 g/L (AUC — 0,690, sensitivity — 77,21 %, specificity — 55,1 %), as well as hypoalbuminemia (AUC — 0,905, sensitivity — 78,89 %, specificity — 91,18 %) statistically significantly increased the likelihood of death by 19 (OR 19.276, 95 % CI [7,792–47.687], p < 0.001), 4 (OR 4.158, 95 % CI [2.177–7.939], p < 0.001), and 30 (OR 30,000, 95 % CI [9.93–90,610], p < 0.001) times, respectively. The statistical analysis using the univariate logistic regression model revealed that such diseases as coronary artery disease (OR 8,6, 95 % CI [2,6–28,466], p < 0.001), chronic heart failure (CHF) (OR 13,714, 95 % CI [4,784–39,313], p < 0.001), atrial fibrillation (OR 3,455, 95 % CI [1,830–6,525], p < 0.001), type 2 diabetes (OR 2.5, 95 % CI [1,286–4,858[, p = 0.007), postinfarction cardiosclerosis (OR 3,734, 95 % CI [1,953–7,142], p < 0.001), and previous stroke (OR 3,319, 95 % CI [1,519–6,490], p = 0.002) made an independent contribution to death prediction. During the study, we calculated the patients’ serum albumin-to-creatinine ratio (sACR). ROC analysis revealed a cut-off point for sACR to be 0.33 g/mmol as having the best predictive ability of death (AUC — 0.920, 84.3 % sensitivity, 85.29 % specificity). It was established that sACR less than 0.33 g/mmol increased the probability of death by 26 times (OR 26.3806, 95 % CI [9.4573.57], p < 0.001).   CONCLUSION. Serum albumin-to-creatinine content ratio can be used as a predictor of fatal outcome in comorbid patients with thrombotic complications.

  • Open Access

    COVID-19 and Cardiovascular System. Part 3. COVID-19 Current Treatment Approaches: Evidence-Based Review

    by M. K. Vasilchenko, A. A. Ivannikov, A. N. Yesaulenko, Kh. G. Alidzhanova, S. S. Petrikov

    Unified management plan and treatment strategy for COVID-19 patients are yet to be discovered. Many trials on COVID-19 interventions have been registered or are ongoing. In this article the results of large-scale clinical trials on COVID-19 treatment are presented, the potential mechanism of action of some drugs is discussed, the features of the main pharmacological and non-pharmacological therapeutic options for COVID-19 patients are described.

  • Open Access

    COVID-19 and Cardiovascular System. Part II. Post-COVID Syndrome

    by A. A. Ivannikov, A. N. Esaulenko, M. K. Vasilchenko, Kh. G. Alidzhanova, S. S. Petrikov

    Ong-term consequences of COVID-19 remain the subject of active research interest. In this article the Post-COVID-19 syndrome (PCS) main features and symptoms are considered, its incidence and link with comorbidity is presented and the possible mechanisms are discussed. Due to the damage COVID-19 has on lungs, heart, brain and other systems, patients with PCS require multidisciplinary management.